Advertisement

Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x100px
Organisation › Details

Hudson Research Center, The

HiberCell is the first company exclusively focused on tumor dormancy detection and therapeutics. The company is developing first-in-class therapeutics that target dormant disseminated tumor cells (DTCs) from solid and liquid cancers, with the ultimate goal of preventing cancer relapse and metastasis. *

 

Period Start 2019-02-07 existent
Products Industry business park management / science park management
  Industry 2 LIFE SCIENCES
     
Region Region New York, NY
  Country United States (USA)
  Street 619 West 54th Street
  City 10019 New York, NY
    Address record changed: 2019-02-13
     
Basic data Employees n. a.
     
    * Document for »About Section«: HiberCell Inc.. (2/7/19). "Press Release: HiberCell Launches to Prevent Cancer Relapse and Metastasis with Novel Therapeutics. $60.75M Funding Round Led by ARCH Venture Partners with 6 Dimensions Capital". New York, NY.
     
   
Record changed: 2019-02-13

Advertisement

Picture Berlin Partner German Biotech Days 2024 in Berlin 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x300px




» top